| 영문 | rotavirus | 한글 | 로타바이러스 |
|---|---|---|---|
| 설명 | 쌍가닥 RNA 바이러스의 일군으로서 바퀴모양의 외관을 가진다. 이 바이러스는 창자의 상피세포에서 복제되고, 특히 급성 영아 위창자염을 일으킨다. 또한 쥐, 송아지 및 돼지의 설사를 일으키기도 한다. 사람의 감염은 겨울에 최고조에 달한다. |
||
| HRV | heart rate variability; human reovirus; human rotavirus |
|---|
| ADRV | Adult Diarrhoea Rotavirus |
|---|---|
| BRV | Bovine rotavirus |
| GBR | group B rotavirus |
| HRV | Human rotavirus |
| RRV | Rhesus rotavirus |
| Rotavirus | <virology> Genus of the Reoviridae having a double layered capsid and 11 double stranded RNA molecules in the genome. They have a wheel like appearance in the electron microscope and cause acute diarrhoeal disease in their mammalian and avian hosts. Probably the most important cause of severe dehydrating diarrhoea in children under three years of age worldwide. Symptoms include nausea, vomiting, low-grade fever and diarrhoea. Aggressive fluid replacement is generally required. (27 Sep 1997) |
|---|---|
| rotavirus antigen test | <investigation, microbiology> A test which detects the presence of rotavirus in the stool. This virus is a common cause of childhood gastroenteritis. (17 Dec 1997) |
| rotavirus infections | Infection with any of the rotaviruses. Specific infections include human infantile diarrhoea, neonatal calf diarrhoea, and epidemic diarrhoea of infant mice. (12 Dec 1998) |
| rotavirus stool test | <investigation> A test which detects the presence of rotavirus in the stool. This virus is a common cause of childhood gastroenteritis. (17 Dec 1997) |
| aids vaccines | Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent aids. Some vaccines containing antigens are recombinantly produced. (12 Dec 1998) |
| bacterial vaccines | Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. (12 Dec 1998) |
| cancer vaccines | Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumour cells as the source of antigens, or using tumour-specific antigens, often recombinantly produced. (12 Dec 1998) |
| vaccines | Vaccines are microbial preparations of killed or modified microorganisms which can stimulate an immune response in the body in order to prevent future infection with similar microorganism. The smallpox vaccine has totally eliminated the smallpox disease from our planet. (12 Dec 1998) |
| vaccines, attenuated | Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. (12 Dec 1998) |
| vaccines, combined | Two or more vaccines in a single dosage form. (12 Dec 1998) |
| vaccines, conjugate | Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognised by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection. (12 Dec 1998) |
| vaccines, DNA | Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers. (12 Dec 1998) |
| vaccines, inactivated | Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins. (12 Dec 1998) |
| vaccines, synthetic | Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified. (12 Dec 1998) |
| malaria vaccines | Vaccines made from antigens arising from any of the four strains of plasmodium which cause malaria in humans, or from p. Berghei which causes malaria in rodents. (12 Dec 1998) |
Synonyms : Vaccines, Rotavirus
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|